Gelatin Capsules Manufacturing - DPR

Gelatin capsules are widely used oral dosage forms in the pharmaceutical, nutraceutical, and dietary supplement industries for encapsulating medicines, vitamins, minerals, herbal extracts, and specialty formulations. These capsules are primarily made from pharmaceutical-grade gelatin derived from collagen, along with plasticizers and purified water, offering excellent bioavailability, ease of swallowing, and precise dosage delivery.

Gelatin capsules are broadly classified into hard gelatin capsules and soft gelatin capsules. Hard gelatin capsules are commonly used for powders, granules, and pellets, while soft gelatin capsules are used for liquids, oils, suspensions, and semi-solid formulations. Gelatin capsules are preferred globally due to their rapid dissolution, compatibility with a wide range of active ingredients, and proven safety profile.

The manufacturing process involves gelatin preparation, capsule shell formation, drying, trimming, inspection, and packaging under controlled environmental conditions. Advanced capsule manufacturing lines ensure uniform wall thickness, moisture control, and dimensional accuracy to meet pharmacopoeial standards. Gelatin capsules comply with global pharmacopeia requirements such as USP, EP, BP, and IP, making them suitable for domestic as well as export markets.

Rising consumption of pharmaceutical products, growth of nutraceuticals and dietary supplements, and increasing preference for encapsulated dosage forms have significantly contributed to the growing demand for gelatin capsules. India has emerged as a key manufacturing hub due to strong pharmaceutical infrastructure, cost advantages, and regulatory compliance capabilities, while global demand is driven by expanding healthcare and wellness markets.

Growth Drivers

• Increasing pharmaceutical and nutraceutical consumption worldwide
• Growing demand for dietary supplements and herbal formulations
• Preference for easy-to-swallow and fast-dissolving dosage forms
• Expansion of contract manufacturing and export-oriented pharma units
• Rising healthcare awareness and aging population

Market Size & Outlook

Global Market:

• The gelatin market size was valued at USD 7.05 billion in 2024 and is projected to reach USD 13.14 billion by 2030, growing at a CAGR of 11.1% from 2025 to 2030.
• Europe dominated the market with the highest revenue share of 38.3% in 2024.
• In terms of source, bovine sourced gelatin segment accounted for the largest market revenue share of 35.1% in 2024.

India Market:

• The Indian gelatin market size, valued at USD 287.13 million in 2025, is expected to reach USD 410.35 million by 2030, growing at a CAGR of 7.40%.

The project reports provide detailed insights into:

• Industrial overview and pharmaceutical market feasibility
• Technical and manufacturing feasibility
• Regulatory and pharmacopoeial compliance
• Sales feasibility and market positioning
• Infrastructure, cleanroom, and operational planning

These reports offer a comprehensive feasibility analysis along with suitable business models and structured implementation plans.

Is gelatin capsule manufacturing a viable business?

Yes. The business benefits from consistent demand from pharmaceutical and nutraceutical industries and strong export potential.

What are the major end-use industries?

Pharmaceuticals, nutraceuticals, dietary supplements, herbal products, and healthcare formulations.

Are bank loans and funding options available?

Yes. The project reports are suitable for MSME loans, pharmaceutical sector financing, and investor funding.

What approvals are required?

Manufacturing requires drug manufacturing license, GMP compliance, pollution control clearance, and adherence to pharmacopeial standards